|
Volumn 10, Issue 4, 2009, Pages 403-404
|
Rebound cataplexy after withdrawal from antidepressants
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOMIPRAMINE;
HLA DQB1 ANTIGEN;
IMIPRAMINE;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
CATAPLEXY;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG WITHDRAWAL;
EDITORIAL;
ELECTROENCEPHALOGRAM;
ELECTROMYOGRAM;
ELECTROOCULOGRAM;
HEREDITY;
HLA TYPING;
HUMAN;
PATIENT EDUCATION;
PATIENT SELECTION;
PRIORITY JOURNAL;
REBOUND CATAPLEXY;
RISK FACTOR;
SEDATION;
SEXUAL DYSFUNCTION;
SIDE EFFECT;
SLEEP DISORDER;
TREATMENT DURATION;
TREATMENT RESPONSE;
XEROSTOMIA;
ANTIDEPRESSIVE AGENTS;
CATAPLEXY;
HUMANS;
SUBSTANCE WITHDRAWAL SYNDROME;
|
EID: 67349190001
PISSN: 13899457
EISSN: None
Source Type: Journal
DOI: 10.1016/j.sleep.2008.06.004 Document Type: Editorial |
Times cited : (7)
|
References (9)
|